DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years-Reference-Cited by-同舟云学术

DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years

Published:2016-08-05 Issue:3 Volume:70 Page:250-254
ISSN:0021-9746
Container-title:Journal of Clinical Pathology
language:en
Short-container-title:J Clin Pathol

Author:

Hubers A Jasmijn,Heideman Daniëlle A M,Duin Sylvia,Witte Birgit I,de Koning Harry J,Groen Harry J M,Prinsen Clemens F M,Bolijn Anne S,Wouters Mandy,van der Meer Susanne E,Steenbergen Renske D M,Snijders Peter J F,Uyterlinde Anne,Berkhof Hans,Smit Egbert F,Thunnissen Erik

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference19 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening;National Lung Screening Trial Research Team;N Engl J Med,2011

2. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort;Belinsky;Cancer Res,2006

3. Molecular sputum analysis for the diagnosis of lung cancer;Hubers;Br J Cancer,2013

4. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON);van Iersel;Int J Cancer,2007

5. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial;Horeweg;Eur Respir J,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in the clinical application of gene methylation for early cancer detection;Frontiers in Epigenetics and Epigenomics;2024-07-19

2. Progress in Cervical Cancer Biomarkers;Clinical and Experimental Obstetrics & Gynecology;2024-04-03

3. Methylated Cell-Free Tumor DNA in Sputum as a Tool for Diagnosing Lung Cancer—A Systematic Review and Meta-Analysis;Cancers;2024-01-24

4. Biomarkers of lung cancer for screening and in never-smokers—a narrative review;Translational Lung Cancer Research;2023-10

5. The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis;PLOS ONE;2023-03-23